AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30334943 — intervention group
Group type: EXPERIMENTAL
Intervention: 260-cm Amplatz Super Stiff guidewire
Number of subjects: 500
Study 30334943 — intervention group
Group type: COMPARATOR
Intervention: 150-cm Emerald guidewire standard J‐tip
Number of subjects: 500
Study 30334943 — intervention group
Group type: COMPARATOR
Intervention: 150-cm Radifocus guidewire M
Number of subjects: 500
Study 27128199 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir pellets
Number of subjects: 77
Study 27128199 — intervention group
Group type: COMPARATOR
Intervention: Lopinavir/ritonavir syrups
Number of subjects: 77
Study 27128199 — intervention group
Group type: COMPARATOR
Intervention: Lopinavir/ritonavir tablets
Number of subjects: 77
Study 24384831 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin glue (Tissucol)
Number of subjects: 23
Study 24384831 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine serum albumin glutaraldehyde surgical adhesive (BioGlue)
Number of subjects: 23
Study 24384831 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Tissucol and BioGlue)
Number of subjects: 23
Study 23244011 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive psychodynamic psychotherapy (SPP) in addition to treatment as usual (TaU)
Number of subjects: 269
Study 23244011 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TaU)
Number of subjects: 269
Study 21146658 — intervention group
Group type: EXPERIMENTAL
Intervention: Discharge antiplatelet therapy (AT)
Number of subjects: 8582
Study 21146658 — intervention group
Group type: COMPARATOR
Intervention: No discharge antiplatelet therapy (AT)
Number of subjects: 8582
Study 21146658 — intervention group
Group type: EXPERIMENTAL
Intervention: Discharge monotherapy
Number of subjects: 8582
Study 21146658 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention
Number of subjects: 8582
Study 21146658 — intervention group
Group type: COMPARATOR
Intervention: No percutaneous coronary intervention
Number of subjects: 8582
Study 18162245 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentavalent rotavirus vaccine (PRV)
Number of subjects: 71799
Study 18162245 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71799
Study 15761435 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus ointment 0.1%
Number of subjects: 0
Study 15761435 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study 12389066 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan (2 mg i.v.)
Number of subjects: 12
Study 12389066 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan (2 mg i.v.) with carvedilol (25 mg orally, twice daily for 7-9 days)
Number of subjects: 12
Study 12389066 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan with carvedilol
Number of subjects: 12
Study 10335933 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide, methotrexate and 5‐fluorouracil (CMF)
Number of subjects: 41
Study 10335933 — intervention group
Group type: EXPERIMENTAL
Intervention: CMF and tamoxifen (TAM)
Number of subjects: 41
Study 10335933 — intervention group
Group type: EXPERIMENTAL
Intervention: TAM alone
Number of subjects: 41
Study 10335933 — intervention group
Group type: EXPERIMENTAL
Intervention: CMF and TAM
Number of subjects: 41
Study 7488393 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% Salicylic Acid (SA) for 6 hours
Number of subjects: 0
Study 7488393 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% Salicylic Acid (SA) for 3 hours
Number of subjects: 0
Study 7488393 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% Urea for 3 hours
Number of subjects: 0
Study 7488393 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% Urea for 6 hours
Number of subjects: 0
Study 1955741 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide (MCP)
Number of subjects: 91
Study 1955741 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (MCP) + Diphenhydramine
Number of subjects: 91
Study 1955741 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine
Number of subjects: 91
Study 7078288 — intervention group
Group type: EXPERIMENTAL
Intervention: Price-information group (received test order forms with prices of diagnostic tests printed)
Number of subjects: 59
Study 7078288 — intervention group
Group type: COMPARATOR
Intervention: Control group (received test order forms with no prices indicated)
Number of subjects: 59
Study 7078288 — intervention group
Group type: EXPERIMENTAL
Intervention: Price-information group
Number of subjects: 59
Study 7078288 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 59
Study 30150003 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS (A‐tDCS) 1 mA
Number of subjects: 74
Study 30150003 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS (S‐tDCS)
Number of subjects: 74
Study 30150003 — intervention group
Group type: EXPERIMENTAL
Intervention: A‐tDCS
Number of subjects: 74
Study 26878875 — intervention group
Group type: EXPERIMENTAL
Intervention: SIT (specific immunotherapy)
Number of subjects: 35
Study 26878875 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific immunotherapy)
Number of subjects: 35
Study 25896265 — intervention group
Group type: EXPERIMENTAL
Intervention: Survivorship Care Plan (SCP)
Number of subjects: 408
Study 25896265 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 408
Study 25896265 — intervention group
Group type: EXPERIMENTAL
Intervention: SCP
Number of subjects: 408
Study 22963921 — intervention group
Group type: EXPERIMENTAL
Intervention: Public Health Nursing (PHN) intervention
Number of subjects: 432
Study 22963921 — intervention group
Group type: EXPERIMENTAL
Intervention: Recession exposure
Number of subjects: 432
Study 22963921 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 432
Study 20628237 — intervention group
Group type: EXPERIMENTAL
Intervention: letrozole (2.5 mg/day)
Number of subjects: 91
Study 20628237 — intervention group
Group type: EXPERIMENTAL
Intervention: oxandrolone (2.5 mg/day)
Number of subjects: 91
Study 20628237 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 91
Study 18381709 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric antidepressant treatment
Number of subjects: 0
Study 18381709 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalizability judgments
Number of subjects: 0
Study 16374149 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 mL/kg predicted body weight tidal volume group
Number of subjects: 861
Study 16374149 — intervention group
Group type: COMPARATOR
Intervention: 6 mL/kg predicted body weight tidal volume group
Number of subjects: 861
Study 15522044 — intervention group
Group type: EXPERIMENTAL
Intervention: Perometer
Number of subjects: 20
Study 15522044 — intervention group
Group type: COMPARATOR
Intervention: Water volumeter
Number of subjects: 20
Study 15522044 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 20
Study 10894864 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine 1,000 mg/m² on days 1, 8, and 15 and cisplatin 100 mg/m² on day 2, every 4 weeks (induction chemotherapy)
Number of subjects: 47
Study 9373482 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronidase group (150 IU/ml hyaluronidase in anaesthetic solution)
Number of subjects: 92
Study 1606337 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Nutrient Admixtures (TNA)
Number of subjects: 96
Study 1606337 — intervention group
Group type: COMPARATOR
Intervention: Piggyback (PB) administration of lipids
Number of subjects: 96
Study 4017309 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasmapheresis
Number of subjects: 18
Study 4017309 — intervention group
Group type: COMPARATOR
Intervention: Total lymphoid irradiation
Number of subjects: 18
Study 3661391 — intervention group
Group type: COMPARATOR
Intervention: Sex hormone levels (total and free testosterone, total and free estradiol, androstenedione, estrone) measured in cases and controls.
Number of subjects: 163
Study 3661391 — intervention group
Group type: COMPARATOR
Intervention: Controlling for other cardiovascular risk factors.
Number of subjects: 163
Study 29443399 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose intravenous soybean oil (LOW)
Number of subjects: 30
Study 29443399 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose intravenous soybean oil (CON)
Number of subjects: 30
Study 26502000 — intervention group
Group type: COMPARATOR
Intervention: Smoking abstinence for 7 years in former smokers (control arm)
Number of subjects: 0
Study 26502000 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking abstinence for 15 years combined with LDCT screening
Number of subjects: 0
Study 26502000 — intervention group
Group type: COMPARATOR
Intervention: Current smokers
Number of subjects: 0
Study 24695927 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 240
Study 24695927 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 240
Study 24695927 — intervention group
Group type: COMPARATOR
Intervention: Vitamin C (placebo)
Number of subjects: 240
Study 22177579 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV DNA and cytology co-testing
Number of subjects: 22420
Study 22177579 — intervention group
Group type: COMPARATOR
Intervention: Cytology testing alone
Number of subjects: 22420
Study 19938977 — intervention group
Group type: EXPERIMENTAL
Intervention: zidovudine-lamivudine plus Nevirapine
Number of subjects: 600
Study 19938977 — intervention group
Group type: EXPERIMENTAL
Intervention: zidovudine-lamivudine plus Abacavir
Number of subjects: 600
Study 19039919 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional oral hygiene treatment including plaque and calculus removal, root planing, motivation and instruction
Number of subjects: 80
Study 19039919 — intervention group
Group type: COMPARATOR
Intervention: Control group (only periodontal status recorded)
Number of subjects: 80
Study 19039919 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional oral hygiene treatment
Number of subjects: 80
Study 15866609 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdose GnRH agonist protocol
Number of subjects: 48
Study 15866609 — intervention group
Group type: COMPARATOR
Intervention: Ganirelix acetate (GnRH antagonist protocol)
Number of subjects: 48
Study 12766692 — intervention group
Group type: EXPERIMENTAL
Intervention: EX/RP alone
Number of subjects: 62
Study 12766692 — intervention group
Group type: EXPERIMENTAL
Intervention: EX/RP with medication
Number of subjects: 62
Study 12766692 — intervention group
Group type: COMPARATOR
Intervention: Serotonergic medications (fluvoxamine or clomipramine)
Number of subjects: 62
Study 10693877 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib 25 mg once daily
Number of subjects: 775
Study 10693877 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib 50 mg once daily
Number of subjects: 775
Study 10693877 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen 800 mg three times daily
Number of subjects: 775
Study 10693877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 775
Study 9113011 — intervention group
Group type: EXPERIMENTAL
Intervention: ICCE with an ACIOL in their first operated eye
Number of subjects: 2000
Study 9113011 — intervention group
Group type: COMPARATOR
Intervention: Standard surgery - ICCE with aphakic correction
Number of subjects: 2000
Study 8018887 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammography screening (not specified dosage or duration)
Number of subjects: 1367
Study 8018887 — intervention group
Group type: COMPARATOR
Intervention: No autopsy
Number of subjects: 1367
Study 3804539 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking two cigarettes
Number of subjects: 8
Study 31426623 — intervention group
Group type: EXPERIMENTAL
Intervention: Baska Mask
Number of subjects: 97
Study 31426623 — intervention group
Group type: COMPARATOR
Intervention: i-gel
Number of subjects: 97
Study 29235571 — intervention group
Group type: EXPERIMENTAL
Intervention: High CAIX expression
Number of subjects: 203
Study 29235571 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia-inducible factor-1α
Number of subjects: 203
Study 29235571 — intervention group
Group type: EXPERIMENTAL
Intervention: GLUT1
Number of subjects: 203
Study 29235571 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbonic anhydrase IX (CAIX)
Number of subjects: 203
Study 27775810 — intervention group
Group type: EXPERIMENTAL
Intervention: Humanized nursing combined with wet healing therapy
Number of subjects: 50
Study 27775810 — intervention group
Group type: COMPARATOR
Intervention: Traditional method of treatment for pressure ulcer
Number of subjects: 50
Study 24589954 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antibiotic therapy
Number of subjects: 24
Study 24589954 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular antibiotic therapy
Number of subjects: 24
Study 23078434 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified introducer method (Group II)
Number of subjects: 62
Study 23078434 — intervention group
Group type: COMPARATOR
Intervention: Pull method (Group I)
Number of subjects: 62
Study 19906790 — intervention group
Group type: EXPERIMENTAL
Intervention: Eucaloric diet (EU; approximately 1800 kcal)
Number of subjects: 23
Study 19906790 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypocaloric diet (HYPO; approximately 1300 kcal)
Number of subjects: 23
Study 18628275 — intervention group
Group type: EXPERIMENTAL
Intervention: OPC-3
Number of subjects: 61
Study 16185404 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral feeding of 50 g/L glucose normal saline (GNS) 500 ml per day containing L‐Arg (400 mg/kg.day) for 4 days (Group A)
Number of subjects: 20
Study 16185404 — intervention group
Group type: COMPARATOR
Intervention: Enteral feeding with only 50 g/L GNS 500 ml per day for 4 days (Group C)
Number of subjects: 20
Study 11822961 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiochemotherapy (2 cycles of fluorouracil, 4500 rad)
Number of subjects: 226
Study 11822961 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preoperative radiochemotherapy)
Number of subjects: 226
Study 11822961 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiochemotherapy
Number of subjects: 226
Study 11101479 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant sterols from rice bran oil (2.1 g/d)
Number of subjects: 60
Study 11101479 — intervention group
Group type: EXPERIMENTAL
Intervention: Triterpene alcohols from sheanut oil (2.6 g/d)
Number of subjects: 60
Study 11101479 — intervention group
Group type: COMPARATOR
Intervention: Control margarine based on sunflower oil
Number of subjects: 60
Study 8646143 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cream containing aminophylline 3%, isosorbide dinitrate 0.25%, and co-dergocrine mesylate 0.05% for one week
Number of subjects: 36
Study 8646143 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 36
Study 8646143 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cream
Number of subjects: 36
Study 1550073 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1000 mg Ca/d)
Number of subjects: 0
Study 1550073 — intervention group
Group type: COMPARATOR
Intervention: Hypertensive control group
Number of subjects: 0
Study 1550073 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary calcium intake
Number of subjects: 0
Study 3004113 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg captopril
Number of subjects: 28
Study 31599653 — intervention group
Group type: EXPERIMENTAL
Intervention: National BMI growth charts for Iranian children and adolescents
Number of subjects: 22718
Study 31744023 — intervention group
Group type: EXPERIMENTAL
Intervention: Extubation bundle with modified spontaneous breathing trial (SBT) (10 minutes)
Number of subjects: 465
Study 31744023 — intervention group
Group type: EXPERIMENTAL
Intervention: Successfully extubated babies
Number of subjects: 465
Study 28611098 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor and eptifibatide bolus
Number of subjects: 70
Study 28611098 — intervention group
Group type: COMPARATOR
Intervention: Ticagrelor and eptifibatide bolus with 2-hour infusion
Number of subjects: 70
Study 25574925 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual-based support
Number of subjects: 150
Study 25574925 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual-based support combined with family reminders
Number of subjects: 150
Study 23250568 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 17
Study 23250568 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NMMA (NOS inhibition)
Number of subjects: 17
Study 23250568 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NMMA + ketorolac (combined intervention)
Number of subjects: 17
Study 23250568 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac (cyclooxygenase inhibition)
Number of subjects: 17
Study 23250568 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac + L-NMMA (combined intervention)
Number of subjects: 17
Study 21242235 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease activity score-driven therapy (tight control group)
Number of subjects: 0
Study 21242235 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 0
Study 19619921 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate plus isotonic saline
Number of subjects: 265
Study 19619921 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline alone
Number of subjects: 265
Study 17016601 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-FU-based adjuvant chemotherapy
Number of subjects: 161
Study 14504728 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard foam mattress
Number of subjects: 0
Study 14504728 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflated mattress
Number of subjects: 0
Study 14504728 — intervention group
Group type: EXPERIMENTAL
Intervention: Deflated mattress
Number of subjects: 0
Study 14504728 — intervention group
Group type: COMPARATOR
Intervention: Floor
Number of subjects: 0
Study 14504728 — intervention group
Group type: COMPARATOR
Intervention: Inflated vs Deflated mattress
Number of subjects: 0
Study 14504728 — intervention group
Group type: COMPARATOR
Intervention: All surfaces
Number of subjects: 0
Study 14504728 — intervention group
Group type: COMPARATOR
Intervention: Bed height
Number of subjects: 0
Study 10694831 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (50-100 mg)
Number of subjects: 53
Study 10694831 — intervention group
Group type: COMPARATOR
Intervention: Trandolapril (2-4 mg)
Number of subjects: 53
Study 9219787 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy with 5-ASA tablets 1.6 g/day and 5-ASA enemas 4 g/100 ml twice weekly
Number of subjects: 69
Study 9219787 — intervention group
Group type: COMPARATOR
Intervention: Oral therapy with 5-ASA tablets 1.6 g/day and placebo enemas/twice weekly
Number of subjects: 69
Study 8484646 — intervention group
Group type: COMPARATOR
Intervention: PEEP 0 cm H2O
Number of subjects: 9
Study 8484646 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP 3 cm H2O
Number of subjects: 9
Study 8484646 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP 6 cm H2O
Number of subjects: 9
Study 8484646 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP 9 cm H2O
Number of subjects: 9
Study 3304850 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 40
Study 3304850 — intervention group
Group type: COMPARATOR
Intervention: Oxygen supplementation
Number of subjects: 40
Study 28956697 — intervention group
Group type: EXPERIMENTAL
Intervention: AppleMets (AMS) nutraceutical formulation containing procyanidin B2 from Annurca apples
Number of subjects: 0
Study 28956697 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 28086890 — intervention group
Group type: EXPERIMENTAL
Intervention: HEYMAN intervention (n=26)
Number of subjects: 50
Study 28086890 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (n=24)
Number of subjects: 50
Study 24366914 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal oxygen therapy (NOT) at 3 L/min
Number of subjects: 23
Study 24366914 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide (2 × 250 mg tablets)
Number of subjects: 23
Study 24366914 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sham-NOT/placebo tablets)
Number of subjects: 23
Study 24366914 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal oxygen therapy (NOT)
Number of subjects: 23
Study 24366914 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 23
Study 24187321 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral mirror image with symmetric movements of both arms
Number of subjects: 5
Study 24187321 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral movement of the affected arm
Number of subjects: 5
Study 24187321 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care provided by a licensed physical therapist
Number of subjects: 5
Study 20846271 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga therapy
Number of subjects: 66
Study 20846271 — intervention group
Group type: COMPARATOR
Intervention: Exercise
Number of subjects: 66
Study 20846271 — intervention group
Group type: COMPARATOR
Intervention: Waitlist group
Number of subjects: 66
Study 18284860 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal amphotericin B (AMB) irrigation (20 mg of AMB in 500 mL of normal saline) for 4 weeks
Number of subjects: 70
Study 18284860 — intervention group
Group type: COMPARATOR
Intervention: Placebo (yellowish dye in 500 mL of normal saline) for 4 weeks
Number of subjects: 70
Study 18284860 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal amphotericin B (AMB) irrigation
Number of subjects: 70
Study 18284860 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal amphotericin B (AMB) irrigation and Placebo
Number of subjects: 70
Study 16531113 — intervention group
Group type: EXPERIMENTAL
Intervention: Valacyclovir
Number of subjects: 106
Study 16531113 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganciclovir
Number of subjects: 106
Study 16531113 — intervention group
Group type: COMPARATOR
Intervention: CMV disease
Number of subjects: 106
Study 16531113 — intervention group
Group type: COMPARATOR
Intervention: Asymptomatic CMV infection
Number of subjects: 106
Study 14739732 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 335